Australia In-vitro Toxicology Assays For Cannabis And Nicotine Testing Market Size & Outlook
Australia in-vitro toxicology assays market for cannabis and nicotine testing market, 2017-2028 (US$M)
Related Markets
Australia in-vitro toxicology assays market for cannabis and nicotine testing market highlights
- The Australia in-vitro toxicology assays market for cannabis and nicotine testing market generated a revenue of USD 19.5 million in 2020 and is expected to reach USD 39.0 million by 2028.
- The Australia market is expected to grow at a CAGR of 9.1% from 2021 to 2028.
- In terms of segment, nicotine testing was the largest revenue generating type in 2020.
- Cannabis Testing is the most lucrative type segment registering the fastest growth during the forecast period.
In-vitro toxicology assays market for cannabis and nicotine testing market data book summary
| Market revenue in 2020 | USD 19.5 million |
| Market revenue in 2028 | USD 39.0 million |
| Growth rate | 9.1% (CAGR from 2020 to 2028) |
| Largest segment | Nicotine testing |
| Fastest growing segment | Cannabis Testing |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cannabis Testing, Nicotine Testing |
| Key market players worldwide | Toxikon, Stemina Biomarker Discovery, Broughton, Labstat, Iontox, Integrated Software Solutions, Montrose, Pbr Laboratories |
Other key industry trends
- In terms of revenue, Australia accounted for 1.6% of the global in-vitro toxicology assays market for cannabis and nicotine testing market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China in-vitro toxicology assays market for cannabis and nicotine testing market is projected to lead the regional market in terms of revenue in 2028.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 37.0 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Market Scope
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia in-vitro toxicology assays market for cannabis and nicotine testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro toxicology assays market for cannabis and nicotine testing market will help companies and investors design strategic landscapes.
Nicotine testing was the largest segment with a revenue share of 63.08% in 2020. Horizon Databook has segmented the Australia in-vitro toxicology assays market for cannabis and nicotine testing market based on cannabis testing, nicotine testing covering the revenue growth of each sub-segment from 2017 to 2028.
Reasons to subscribe to Australia in-vitro toxicology assays market for cannabis and nicotine testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia in-vitro toxicology assays market for cannabis and nicotine testing market databook
-
Our clientele includes a mix of in-vitro toxicology assays market for cannabis and nicotine testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia in-vitro toxicology assays market for cannabis and nicotine testing market, including forecasts for subscribers. This country databook contains high-level insights into Australia in-vitro toxicology assays market for cannabis and nicotine testing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Australia in vitro toxicology assays cannabis nicotine testing market report size, by type, 2017-2028 (US$M)
Australia In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Market Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
